http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008511555-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-71 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2005-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008511555-A |
| titleOfInvention | Drugs with analgesic action |
| abstract | It is a kind of drug with analgesic action, and it is composed of an aconitine component as an active drug component and an auxiliary component that can be added in the drug, and the active drug component in it is at least a fusulin compound of the formula (I) structure Contains. This drug has an ideal analgesic function and relatively low toxicity, and it is necessary to prepare a conventional internal preparation, an external preparation containing injections, or detergents, ointments, plugs and medicinal dressings. Can do. It is a group of drugs having a kind of analgesic action, and is a drug formulation prepared so that a compound having the following weight ratio can be used as an active drug component and an auxiliary agent in the drug can be added. Fuziline of the formula (I) structure is 200 to 600 minutes, benzoyl / medium aconitine / unrefined alkali 0 to 600 minutes, medium aconitine / alkali 0 to 3 minutes, lower aconitine / alkali 0 to 6 minutes. |
| priorityDate | 2004-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.